Conditions and diseases
Blood and immune system conditions
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
Technology appraisal guidance [TA386]
23 March 2016
Tools and resources
Information for the public
Review and download supporting evidence. Includes the full guideline if available.